Get Started

Prevent overpayments before they occur. Learn more ↠

Case Study:

20+ years in Partnership with a
Pioneering Pharmaceutical Company

Working with this global pharmaceutical company, we have delivered $800m to the bottom line while preserving supplier relationships through automated mitigation of duplicate payments and a continuous rolling-window supplier statement review.

 

Click here for the full case study.

A line-drawing style image of a syringe and vial

 

 

Financial outcomes:

$

800

m

Value delivered across 20+ years

28

% increase

EMEA recoveries in the one audit cycle

$

600

m

Overpayments prevented with technology

More insights from pharmaceutical clients:

How apexanalytix Helps Charles River Labs Maximize Value Through Recovery Audits

Another apexanalytix client in the pharmaceutical industry, Charles River Labs, ensures financial accuracy and reclaims list value through our services.

 

In this testimonial, their Chief Procurement Officer, Gerard Cardillo, shares how we deliver insights as well as cash.

 

To read more about our partnership with Charles River Labs, click here.

Client-Testimonal-Gerard-Cardillo-CPO-of-Charles-River-Labs

The Biopharma Audit That Returned $25M to the Bottom Line

Read how a nearly two-decade long partnership with a global biopharma audit continues to strengthen financial controls and unlock millions in recoveries.

 

The company’s scale—including a vast supplier network, billions in annual spend, and multiple divisions with differing approval workflows, system configurations, and operational requirements—creates a complex environment that demands rigorous financial oversight.

 

With invoices spanning multiple systems and regions, the risks of unclaimed credits and errors from purchase order changes are significant. Click here to read more.

A pharmaceutical themed image with the caption

Recovering € Millions in Overpayments Missed by ERP Controls

Read how a statement review identified millions of Euros in overpayments that were missed by ERP controls.

 

This European headquartered pharmaceutical giant is a long-term client of apexanalytix. Their recent audit results highlight the limitations of transaction-level ERP controls.

 

During the latest audit period, apexanalytix reviewed €28.6bn in spend across more than 2 million invoices and over 60,000 vendors. Click here to read more.

Recovering € Millions in Overpayments Missed by ERP Controls

Read the report:
"How Pharma Finance Leaders Are Preventing Overpayments and Reclaiming Millions"

faster supplier onboarding with apexanalytix
Auditing closer to the transaction makes sure that we recover all overpayments timely. And insights from apexanalytix give us the information on where to focus and how to fix the gaps in our procure-to-pay process.
Director, Global Process Owner – Invoice to Pay (major pharmaceutical company)

Complete this quick form and we will get back to you within 24 hours.